Home301211 • SHE
add
Hubei Biocause Heilen Pharmacetcl Co Ltd
Nakaraang pagsara
¥19.52
Sakop ng araw
¥19.30 - ¥20.00
Sakop ng taon
¥13.63 - ¥25.96
Market cap
5.64B CNY
Average na Volume
10.23M
P/E ratio
53.30
Dividend yield
2.43%
Primary exchange
SHE
Mga balita tungkol sa merkado
MarketWatch
1 araw ang nakalipas
Wall Street sees ‘no alternative’ to U.S. stocks in 2025. Here’s why.
0.072%
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 92.13M | -32.60% |
Gastos sa pagpapatakbo | 24.55M | -32.38% |
Net na kita | 6.17M | -80.41% |
Net profit margin | 6.69 | -70.95% |
Kita sa bawat share | — | — |
EBITDA | -4.80M | -115.43% |
Aktuwal na % ng binabayarang buwis | -263.67% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.62B | -12.79% |
Kabuuang asset | 2.44B | -2.47% |
Kabuuang sagutin | 141.64M | -17.73% |
Kabuuang equity | 2.30B | — |
Natitirang share | 288.00M | — |
Presyo para makapag-book | 2.45 | — |
Return on assets | -1.01% | — |
Return on capital | -1.07% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 6.17M | -80.41% |
Cash mula sa mga operasyon | 17.00M | -52.31% |
Cash mula sa pag-invest | -518.43M | -1,348.47% |
Cash mula sa financing | 0.00 | 100.00% |
Net change in cash | -501.92M | -62,966.11% |
Malayang cash flow | -21.78M | 35.93% |
Tungkol
Itinatag
Dis 29, 1995
Website
Mga Empleyado
1,012
